Verteporfin photodynamic therapy has been an established treatment for subfoveal myopic CNV for many years, but this treatment does not restore visual acuity and is associated with long-term ...

Exegenesis Bio is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American Society ...

There were 5 categories used to divide myopic maculopathy: absence of myopic-related fundus lesions (C0), tessellated fundus (C1), diffuse chorioretinal atrophy (C2), patchy chorioretinal atrophy ...

In the META-PM classification system, myopic maculopathy lesions are categorized into five categories from no myopic retinal lesions (category 0), tessellated fundus only (category 1, Figure 1A), ...

GACR is a rare autosomal recessive disorder of ornithine metabolism. Clinically, GACR is characterized by progressive chorioretinal atrophy. Patients present in early childhood with complaints of ...

Geographic atrophy is a common form of vision loss in older adults. It is an advanced form of age-related macular degeneration (AMD). It occurs as retinal cells in the macula—a film in the back ...

The team stratified participants into 2 groups, consisting of individuals with high pathologic myopia (patchy chorioretinal atrophy or worse, foveal detachment, active myopic or scar choroidal ...

Gyrate atrophy of choroid and retina (GACR) is a chorioretinal degeneration caused by pathogenic variants in the gene encoding ornithine aminotransferase (OAT), an enzyme mainly expressed in liver.

and chorioretinal atrophy. Advances in ophthalmic bio-imaging modalities have enabled the identification of the fine details of structures and allowed the prediction of risk factors. Earlier ...

Pathologic myopia refers to myopic patients with structural changes in the posterior pole including different patterns of chorioretinal atrophy, choroidal neovascularization (CNV) and vitreomacular ...